The DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
Current Update on Intrinsic and Acquired Colistin Resistance Mechanisms in Bacteria
Open accessAbstract
Colistin regained global interest as a consequence of the rising prevalence of multidrug-resistant Gram-negative Enterobacteriaceae. In parallel, colistin-resistant bacteria emerged in response to the unregulated use of this antibiotic. However, some Gram-negative species are intrinsically resistant to colistin activity, such as Neisseria meningitides, Burkholderia species, and Proteus mirabilis. Most identified colistin resistance usually involves modulation of lipid A that decreases or removes early charge-based interaction with colistin through up-regulation of multistep capsular polysaccharide expression. The membrane modifications occur by the addition of cationic phosphoethanolamine (pEtN) or 4-amino-l-arabinose on lipid A that results in decrease in the negative charge on the bacterial surface. Therefore, electrostatic interaction between polycationic colistin and lipopolysaccharide (LPS) is halted. It has been reported that these modifications on the bacterial surface occur due to overexpression of chromosomally mediated two-component system genes (PmrAB and PhoPQ) and mutation in lipid A biosynthesis genes that result in loss of the ability to produce lipid A and consequently LPS chain, thereafter recently identified variants of plasmid-borne genes (mcr-1 to mcr-10). It was hypothesized that mcr genes derived from intrinsically resistant environmental bacteria that carried chromosomal pmrC gene, a part of the pmrCAB operon, code three proteins viz. pEtN response regulator PmrA, sensor kinase protein PmrAB, and phosphotransferase PmrC. These plasmid-borne mcr genes become a serious concern as they assist in the dissemination of colistin resistance to other pathogenic bacteria. This review presents the progress of multiple strategies of colistin resistance mechanisms in bacteria, mainly focusing on surface changes of the outer membrane LPS structure and other resistance genetic determinants. New handier and versatile methods have been discussed for rapid detection of colistin resistance determinants and the latest approaches to revert colistin resistance that include the use of new drugs, drug combinations and inhibitors. Indeed, more investigations are required to identify the exact role of different colistin resistance determinants that will aid in developing new less toxic and potent drugs to treat bacterial infections. Therefore, colistin resistance should be considered a severe medical issue requiring multisectoral research with proper surveillance and suitable monitoring systems to report the dissemination rate of these resistant genes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Performance standards for antimicrobial susceptibility testing
Ferraro, M. J. (2001) · Cited by 9,667
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
ResFinder 4.0 for predictions of phenotypes from genotypes
Bortolaia, V., Kaas, R. S., Ruppe, E., Roberts, M. C., Schwarz, S., Cattoir, V., Philippon, A., Allesoe, R. L., Rebelo, A. R., Florensa, A. F., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa345 · Cited by 3,373
(2015) · Microbe Magazine · doi:10.1128/microbe.10.354.1 · Cited by 2,266
Microbiological effects of sublethal levels of antibiotics
Andersson, D. I., & Hughes, D. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3270 · Cited by 1,757
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,744
Poirel, L., Jayol, A., & Nordmann, P. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00064-16 · Cited by 1,447
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
Olaitan, A. O., Morand, S., & Rolain, J.-M. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00643 · Cited by 1,395
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Li, J., Nation, R. L., Turnidge, J. D., Milne, R. W., Coulthard, K., Rayner, C. R., & Paterson, D. L. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70580-1 · Cited by 1,388
Talbot, G. H., Bradley, J., Edwards, J. E., Gilbert, D., Scheld, M., & Bartlett, J. G. (2006) · Clinical Infectious Diseases · doi:10.1086/499819 · Cited by 1,104
Origins and evolution of antibiotic resistance.
DAVIES, J. E. (1996) · PubMed · Cited by 1,033
Peterson, E., & Kaur, P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02928 · Cited by 1,006
Tang, K. L., Caffrey, N. P., Nóbrega, D. B., Cork, S. C., Ronksley, P. E., Barkema, H. W., Polachek, A. J., Ganshorn, H., Sharma, N., Kellner, J. D., et al. (2017) · The Lancet Planetary Health · doi:10.1016/s2542-5196(17)30141-9 · Cited by 942
The Pleiotropic Two-Component Regulatory System PhoP-PhoQ
Groisman, E. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.6.1835-1842.2001 · Cited by 887
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Falagas, M. E., & Kasiakou, S. K. (2006) · Critical Care · doi:10.1186/cc3995 · Cited by 828
Antibiotic resistance is the quintessential One Health issue
Robinson, T. P., Bu, D. P., Carrique-Mas, J., Fèvre, E. M., Gilbert, M., Grace, D., Hay, S. I., Jiwakanon, J., Kakkar, M., Kariuki, S., et al. (2016) · Transactions of The Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trw048 · Cited by 828
Moffatt, J. H., Harper, M., Harrison, P., Hale, J. D. F., Vinogradov, E., Seemann, T., Henry, R., Crane, B., St. Michael, F., Cox, A. D., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00834-10 · Cited by 812
Xavier, B. B., Lammens, C., Ruhal, R., Kumar-Singh, S., Butaye, P., Goossens, H., & Malhotra-Kumar, S. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.27.30280 · Cited by 779
Colistin and its role in the Era of antibiotic resistance: an extended review (2000–2019)
El-Sayed Ahmed, M. A. E.-G., Zhong, L.-L., Shen, C., Yang, Y., Doi, Y., & Tian, G.-B. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1754133 · Cited by 761
Polymyxin and Related Peptide Antibiotics
Storm, D. R., Rosenthal, K. S., & Swanson, P. E. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.003451 · Cited by 759
Garonzik, S. M., Li, J., Thamlikitkul, V., Paterson, D. L., Shoham, S., Jacob, J., Silveira, F. P., Forrest, A., & Nation, R. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01733-10 · Cited by 696
The global distribution and spread of the mobilized colistin resistance gene mcr-1
Wang, R., van Dorp, L., Shaw, L. P., Bradley, P., Wang, Q., Wang, X., Jin, L., Zhang, Q., Liu, Y., Rieux, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03205-z · Cited by 662
Marston, H. D., Dixon, D. M., Knisely, J. M., Palmore, T. N., & Fauci, A. S. (2016) · JAMA · doi:10.1001/jama.2016.11764 · Cited by 638
Pollution from drug manufacturing: review and perspectives
Larsson, D. G. J. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0571 · Cited by 596
Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It
Zgurskaya, H. I., López, C. A., & Gnanakaran, S. (2015) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00097 · Cited by 580
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria
Li, J., Nation, R. L., Milne, R. W., Turnidge, J. D., & Coulthard, K. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.10.001 · Cited by 571
Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections
Steenbergen, J. N., Alder, J., Thorne, G. M., & Tally, F. P. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh546 · Cited by 561
Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii
Li, J., Rayner, C. R., Nation, R. L., Owen, R. J., Spelman, D., Tan, K. E., & Liolios, L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00103-06 · Cited by 548
Polymyxin B Sulfate and Colistin: Old Antibiotics for Emerging Multiresistant Gram-Negative Bacteria
Evans, M. E., Feola, D. J., & Rapp, R. P. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18426 · Cited by 544
Novel Plasmid-Mediated Colistin Resistance Gene mcr-3 in Escherichia coli
Yin, W., Li, H., Shen, Y., Liu, Z., Wang, S., Shen, Z., Zhang, R., Walsh, T. R., Shen, J., & Wang, Y. (2017) · mBio · doi:10.1128/mbio.00543-17 · Cited by 537
Carattoli, A., Villa, L., Feudi, C., Curcio, L., Orsini, S., Luppi, A., Pezzotti, G., & Magistrali, C. F. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.31.30589 · Cited by 533
Borowiak, M., Fischer, J., Hammerl, J. A., Hendriksen, R. S., Szabo, I., & Malorny, B. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx327 · Cited by 533
Capsule Polysaccharide Mediates Bacterial Resistance to Antimicrobial Peptides
Campos, M. A., Vargas, M. A., Regueiro, V., Llompart, C. M., Albertí, S., & Bengoechea, J. A. (2004) · Infection and Immunity · doi:10.1128/iai.72.12.7107-7114.2004 · Cited by 518
Carroll, L. M., Gaballa, A., Guldimann, C., Sullivan, G., Henderson, L. O., & Wiedmann, M. (2019) · mBio · doi:10.1128/mbio.00853-19 · Cited by 506
Emergence of a novel mobile colistin resistance gene, mcr-8 , in NDM-producing Klebsiella pneumoniae
Wang, X., Wang, Y., Zhou, Y., Li, J., Yin, W., Wang, S., Zhang, S., Shen, J., Shen, Z., & Wang, Y. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0124-z · Cited by 460
Identification of novel mobile colistin resistance gene mcr-10
Wang, C., Feng, Y., Liu, L., Wei, L., Kang, M., & Zong, Z. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1732231 · Cited by 456
Pharmacology of Polymyxins: New Insights into an ‘Old‘ Class of Antibiotics
Velkov, T., Roberts, K. D., Nation, R. L., Thompson, P. E., & Li, J. (2013) · Future Microbiology · doi:10.2217/fmb.13.39 · Cited by 452
Adams, M. D., Nickel, G. C., Bajaksouzian, S., Lavender, H., Murthy, A. R., Jacobs, M. R., & Bonomo, R. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00284-09 · Cited by 448
Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing
Lim, L. M., Ly, N., Anderson, D., Yang, J. C., Macander, L., Jarkowski, A., Forrest, A., Bulitta, J. B., & Tsuji, B. T. (2010) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.12.1279 · Cited by 444
Klebsiella pneumoniae AcrAB Efflux Pump Contributes to Antimicrobial Resistance and Virulence
Padilla, E., Llobet, E., Doménech-Sánchez, A., Martínez-Martínez, L., Bengoechea, J. A., & Albertí, S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00715-09 · Cited by 431
Hasman, H., Hammerum, A. M., Hansen, F., Hendriksen, R. S., Olesen, B., Agersø, Y., Zankari, E., Leekitcharoenphon, P., Stegger, M., Kaas, R. S., et al. (2015) · Eurosurveillance · doi:10.2807/1560-7917.es.2015.20.49.30085 · Cited by 419
Molecular mechanisms of polymyxin resistance: knowns and unknowns
Baron, S., Hadjadj, L., Rolain, J.-M., & Olaitan, A. O. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.06.023 · Cited by 414
Resistance to polymyxins in Gram-negative organisms
Jeannot, K., Bolard, A., & Plésiat, P. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.11.029 · Cited by 402
Cannatelli, A., Giani, T., D'Andrea, M. M., Di Pilato, V., Arena, F., Conte, V., Tryfinopoulou, K., Vatopoulos, A., & Rossolini, G. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03110-14 · Cited by 374
Novel plasmid-mediated colistin resistance gene mcr-7.1 in Klebsiella pneumoniae
Yang, Y.-Q., Li, Y.-X., Lei, C.-W., Zhang, A.-Y., & Wang, H.-N. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky111 · Cited by 367
Cannatelli, A., D'Andrea, M. M., Giani, T., Di Pilato, V., Arena, F., Ambretti, S., Gaibani, P., & Rossolini, G. M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01480-13 · Cited by 351
Stokes, J. M., MacNair, C. R., Ilyas, B., French, S., Côté, J.-P., Bouwman, C., Farha, M. A., Sieron, A. O., Whitfield, C., Coombes, B. K., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.28 · Cited by 340
Gunn, J. S. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2008.03.007 · Cited by 332
Zankari, E., Hasman, H., Kaas, R. S., Seyfarth, A. M., Agerso, Y., Lund, O., Larsen, M. V., & Aarestrup, F. M. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks496 · Cited by 325
Capsule polysaccharide is a bacterial decoy for antimicrobial peptides
Llobet, E., Tomás, J. M., & Bengoechea, J. A. (2008) · Microbiology · doi:10.1099/mic.0.2008/022301-0 · Cited by 312
Matuschek, E., Åhman, J., Webster, C., & Kahlmeter, G. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.11.020 · Cited by 311
Gales, A. C., Jones, R. N., & Sader, H. S. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01351.x · Cited by 302
The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae
Poirel, L., Jayol, A., Bontron, S., Villegas, M.-V., Ozdamar, M., Turkoglu, S., & Nordmann, P. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku323 · Cited by 302
Hoelzer, K., Wong, N., Thomas, J., Talkington, K., Jungman, E., & Coukell, A. (2017) · BMC Veterinary Research · doi:10.1186/s12917-017-1131-3 · Cited by 301
Resistance to polymyxins: Mechanisms, frequency and treatment options
Falagas, M. E., Rafailidis, P. I., & Matthaiou, D. K. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.05.002 · Cited by 298
Olaitan, A. O., Diene, S. M., Kempf, M., Berrazeg, M., Bakour, S., Gupta, S. K., Thongmalayvong, B., Akkhavong, K., Somphavong, S., Paboriboune, P., et al. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.07.020 · Cited by 292
A review on colistin nephrotoxicity
Ordooei Javan, A., Shokouhi, S., & Sahraei, Z. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1865-4 · Cited by 287
Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics
MacNair, C. R., Stokes, J. M., Carfrae, L. A., Fiebig-Comyn, A. A., Coombes, B. K., Mulvey, M. R., & Brown, E. D. (2018) · Nature Communications · doi:10.1038/s41467-018-02875-z · Cited by 287
AbuOun, M., Stubberfield, E. J., Duggett, N. A., Kirchner, M., Dormer, L., Nunez-Garcia, J., Randall, L. P., Lemma, F., Crook, D. W., Teale, C., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx286 · Cited by 282
Dissemination and Mechanism for the MCR-1 Colistin Resistance
Gao, R., Hu, Y., Li, Z., Sun, J., Wang, Q., Lin, J., Ye, H., Liu, F., Srinivas, S., Li, D., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005957 · Cited by 269
Doumith, M., Godbole, G., Ashton, P., Larkin, L., Dallman, T., Day, M., Day, M., Muller-Pebody, B., Ellington, M. J., de Pinna, E., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw093 · Cited by 263
Colistin: new lessons on an old antibiotic
Yahav, D., Farbman, L., Leibovici, L., & Paul, M. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03734.x · Cited by 259
Dissemination of the mcr-1 colistin resistance gene
Zhi, C., Lv, L., Yu, L.-F., Doi, Y., & Liu, J.-H. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00063-3 · Cited by 258
Rhouma, M., Beaudry, F., Thériault, W., & Letellier, A. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01789 · Cited by 253
Mevius, D. J., Koene, M. G. J., Wit, B., van Pelt, W., & Bondt, N. (2005) · Socio-Environmental Systems Modeling · Cited by 248
Feedback Inhibition in the PhoQ/PhoP Signaling System by a Membrane Peptide
Lippa, A. M., & Goulian, M. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000788 · Cited by 238
Catry, B., Cavaleri, M., Baptiste, K., Grave, K., Grein, K., Holm, A., Jukes, H., Liebana, E., Navas, A. L., Mackay, D., et al. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.06.005 · Cited by 238
Beceiro, A., Moreno, A., Fernández, N., Vallejo, J. A., Aranda, J., Adler, B., Harper, M., Boyce, J. D., & Bou, G. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01597-13 · Cited by 233
Parra-Lopez, C., Baer, M. T., & Groisman, E. A. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06089.x · Cited by 231
Emergence of the mcr-1 colistin resistance gene in carbapenem-resistant Enterobacteriaceae
Du, H., Chen, L., Tang, Y.-W., & Kreiswirth, B. N. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00056-6 · Cited by 226
Monaco, M., Giani, T., Raffone, M., Arena, F., Garcia-Fernandez, A., Pollini, S., Network EuSCAPE-Italy, C., Grundmann, H., Pantosti, A., & Rossolini, G. M. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.42.20939 · Cited by 226
Sorlí, L., Luque, S., Grau, S., Berenguer, N., Segura, C., Montero, M. M., Álvarez-Lerma, F., Knobel, H., Benito, N., & Horcajada, J. P. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-380 · Cited by 225
Miller, A. K., Brannon, M. K., Stevens, L., Johansen, H. K., Selgrade, S. E., Miller, S. I., Høiby, N., & Moskowitz, S. M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05391-11 · Cited by 224
Rojas, L. J., Salim, M., Cober, E., Richter, S. S., Perez, F., Salata, R. A., Kalayjian, R. C., Watkins, R. R., Marshall, S., Rudin, S. D., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw805 · Cited by 224
Srinivasan, V. B., & Rajamohan, G. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02284-12 · Cited by 216
Wright, M. S., Suzuki, Y., Jones, M. B., Marshall, S. H., Rudin, S. D., van Duin, D., Kaye, K., Jacobs, M. R., Bonomo, R. A., & Adams, M. D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04037-14 · Cited by 216
Deris, Z. Z., Akter, J., Sivanesan, S., Roberts, K. D., Thompson, P. E., Nation, R. L., Li, J., & Velkov, T. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2013.111 · Cited by 216
Chew, K. L., La, M.-V., Lin, R. T. P., & Teo, J. W. P. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00268-17 · Cited by 210
Rapid Detection of Polymyxin Resistance in Enterobacteriaceae
Nordmann, P., Jayol, A., & Poirel, L. (2016) · Emerging Infectious Diseases · doi:10.3201/eid2206.151840 · Cited by 204
Jayol, A., Nordmann, P., Brink, A., & Poirel, L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05055-14 · Cited by 203
Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?
Tran, T. B., Velkov, T., Nation, R. L., Forrest, A., Tsuji, B. T., Bergen, P. J., & Li, J. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.09.010 · Cited by 200
Jung, Y., Jang, H., & Matthews, K. R. (2014) · Microbial Biotechnology · doi:10.1111/1751-7915.12178 · Cited by 196
Kaye, K. S., Pogue, J. M., Tran, T. B., Nation, R. L., & Li, J. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.02.005 · Cited by 186
In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae
Poudyal, A., Howden, B. P., Bell, J. M., Gao, W., Owen, R. J., Turnidge, J. D., Nation, R. L., & Li, J. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn425 · Cited by 185
In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates
Owen, R. J., Li, J., Nation, R. L., & Spelman, D. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl512 · Cited by 176
Yan, A., Guan, Z., & Raetz, C. R. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706172200 · Cited by 169
Treatment Options for Colistin Resistant Klebsiella pneumoniae: Present and Future
Petrosillo, N., Taglietti, F., & Granata, G. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070934 · Cited by 167
Elucidation of the RamA Regulon in Klebsiella pneumoniae Reveals a Role in LPS Regulation
De Majumdar, S., Yu, J., Fookes, M., McAteer, S. P., Llobet, E., Finn, S., Spence, S., Monaghan, A., Kissenpfennig, A., Ingram, R. J., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004627 · Cited by 165
Hirakawa, H., Nishino, K., Hirata, T., & Yamaguchi, A. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.6.1851-1856.2003 · Cited by 162
Diene, S. M., Merhej, V., Henry, M., Filali, A. E., Roux, V., Robert, C., Azza, S., Gavory, F., Barbe, V., Scola, B. L., et al. (2012) · Molecular Biology and Evolution · doi:10.1093/molbev/mss236 · Cited by 160
Global antimicrobial resistance in Gram-negative pathogens and clinical need
Theuretzbacher, U. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.10.028 · Cited by 160
Dafopoulou, K., Zarkotou, O., Dimitroulia, E., Hadjichristodoulou, C. S., Gennimata, V., Pournaras, S., & Tsakris, A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00868-15 · Cited by 159
Stepwise evolution of pandrug-resistance in Klebsiella pneumoniae
Zowawi, H. M., Forde, B. M., Alfaresi, M. S., Alzarouni, A., Farahat, Y., Chong, T. M., Yin, W., Chan, K., Li, J., Schembri, M. A., et al. (2015) · Scientific Reports · doi:10.1038/srep15082 · Cited by 158
Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae
Meletis, G., Tzampaz, E., Sianou, E., Tzavaras, I., & Sofianou, D. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr007 · Cited by 154
Possible Transmission ofmcr-1–HarboringEscherichia colibetween Companion Animals and Human
Zhang, X.-F., Doi, Y., Huang, X., Li, H.-Y., Zhong, L., Zeng, K.-J., Zhang, Y.-F., Patil, S., & Tian, G. (2016) · Emerging infectious diseases · doi:10.3201/eid2209.160464 · Cited by 153
Yau, W., Owen, R. J., Poudyal, A., Bell, J. M., Turnidge, J. D., Yu, H. H., Nation, R. L., & Li, J. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.11.002 · Cited by 152
Bulitta, J. B., Yang, J. C., Yohonn, L., Ly, N. S., Brown, S. V., D'Hondt, R. E., Jusko, W. J., Forrest, A., & Tsuji, B. T. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00881-09 · Cited by 152
Dissemination of the mcr-1 colistin resistance gene
Webb, H. E., Granier, S. A., Marault, M., Millemann, Y., den Bakker, H. C., Nightingale, K. K., Bugarel, M., Ison, S. A., Scott, H. M., & Loneragan, G. H. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00538-1 · Cited by 148
Impact of food animal trade on the spread of mcr-1-mediated colistin resistance, Tunisia, July 2015
Grami, R., Mansour, W., Mehri, W., Bouallègue, O., Boujâafar, N., Madec, J.-Y., & Haenni, M. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.8.30144 · Cited by 145
Cheng, Y.-H., Lin, T., Lin, Y.-T., & Wang, J.-T. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00009-16 · Cited by 142
Munguia, J., & Nizet, V. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.02.003 · Cited by 140
Tyson, G. H., Li, C., Hsu, C.-H., Ayers, S. L., Borenstein, S., Mukherjee, S., Tran, T.-T., McDermott, P. F., & Zhao, S. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00573-20 · Cited by 139
Stoesser, N. E., Mathers, A. J., Moore, C. E., Day, N., & Crook, D. W. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00010-4 · Cited by 136
Scott, A. M., Beller, E., Glasziou, P., Clark, J. M., Ranakusuma, R. W., Byambasuren, O., Bakhit, M., Page, S. W., Trott, D. J., & Mar, C. D. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.04.005 · Cited by 135
Ye, H., Li, Y., Li, Z., Gao, R., Zhang, H., Wen, R., Gao, G. F., Hu, Q., & Feng, Y. (2016) · mBio · doi:10.1128/mbio.00177-16 · Cited by 134
Ni, W., Li, Y., Guan, J., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00248-16 · Cited by 129
Identification of Proteus mirabilis Mutants with Increased Sensitivity to Antimicrobial Peptides
McCoy, A. J., Liu, H., Falla, T. J., & Gunn, J. S. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2030-2037.2001 · Cited by 128
Genetic Analysis of Colistin Resistance in Salmonella enterica Serovar Typhimurium
Sun, S., Negrea, A., Rhen, M., & Andersson, D. I. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01016-08 · Cited by 125
Bos, M. E. H., Taverne, F. J., van Geijlswijk, I. M., Mouton, J. W., Mevius, D. J., Heederik, D. J. J., & (SDa), O. B. O. T. N. V. M. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077525 · Cited by 124
Nhu, N. T. K., Riordan, D. W., Nhu, T. D. H., et al. (2016) · Scientific Reports · doi:10.1038/srep28291 · Cited by 123
Zoonotic Transmission ofmcr-1Colistin Resistance Gene from Small-Scale Poultry Farms, Vietnam
Trung, N. V., Matamoros, S., Carrique-Mas, J. J., Nghĩa, N. H., Nhung, N. T., Chiêu, T. T. B., Mai, H. H., van Rooijen, W. J. M., Campbell, J. I., Wagenaar, J. A., et al. (2017) · Emerging infectious diseases · doi:10.3201/eid2303.161553 · Cited by 118
Expanding landscapes of the diversified mcr-1-bearing plasmid reservoirs
Wang, Q., Sun, J. G., Li, J., Ding, Y., Li, X., Lin, J., Hassan, B. H., & Feng, Y. (2017) · Microbiome · doi:10.1186/s40168-017-0288-0 · Cited by 116
Polymyxins and Their Potential Next Generation as Therapeutic Antibiotics
Vaara, M. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01689 · Cited by 113
Leakage of periplasmic proteins from Escherichia coli mediated by polymyxin B nonapeptide
DIXON, R. A., & Chopra, I. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.5.781 · Cited by 112
A Universal Culture Medium for Screening Polymyxin-Resistant Gram-Negative Isolates
Nordmann, P., Jayol, A., & Poirel, L. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00446-16 · Cited by 111
Novel Antibiotics for Multidrug-Resistant Gram-Positive Microorganisms
Koulenti, D., Xu, E., Mok, I. Y. S., Song, A., Karageorgopoulos, D. E., Armaganidis, A., Lipman, J., & Tsiodras, S. (2019) · Microorganisms · doi:10.3390/microorganisms7080270 · Cited by 111
Wanty, C., Anandan, A., Piek, S., Walshe, J. L., Ganguly, J., Carlson, R. W., Stubbs, K. A., Kahler, C. M., & Vrielink, A. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.06.029 · Cited by 110
Thanh, D. P., Tuyen, H. T., Nguyen, T. N. T., The, H. C., Wick, R. R., Thwaites, G. E., Baker, S. G., & Holt, K. E. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw173 · Cited by 110
Brennan-Krohn, T., Pironti, A., & Kirby, J. E. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00873-18 · Cited by 110
WHO Global Antimicrobial Resistance Surveillance System early implementation 2016–17
Tornimbene, B., Eremin, S., Escher, M., Griskeviciene, J., Manglani, S., & Pessoa-Silva, C. L. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30060-4 · Cited by 107
Contribution of EmrAB efflux pumps to colistin resistance in Acinetobacter baumannii
Lin, M.-F., Lin, Y.-Y., & Lan, C. (2017) · The Journal of Microbiology · doi:10.1007/s12275-017-6408-5 · Cited by 105
Susceptibility Testing of the Polymyxins: Where Are We Now?
Humphries, R. M. (2014) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1505 · Cited by 99
Zeng, K.-J., Doi, Y., Patil, S., Huang, X., & Tian, G. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00345-16 · Cited by 99
Dong, H., Xiang, H., Mu, D., Wang, D., & Wang, T. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.09.017 · Cited by 99
Guenther, S., Falgenhauer, L., Semmler, T., Imirzalioglu, C., Chakraborty, T., Roesler, U. H., & Roschanski, N. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw585 · Cited by 98
Jones‐Dias, D., Manageiro, V., Ferreira, E., Barreiro, P., Vieira, L., Moura, I. B., & Caniça, M. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01400 · Cited by 97
Sherry, N. L., & Howden, B. P. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1453807 · Cited by 94
Genetic Determinants of Intrinsic Colistin Tolerance in Acinetobacter baumannii
Hood, M. I., Becker, K. W., Roux, C. M., Dunman, P. M., & Skaar, E. P. (2012) · Infection and Immunity · doi:10.1128/iai.00704-12 · Cited by 93
Lima, W. G., Alves, M. C., Nizer, W. S. D. C., & de Paiva, M. C. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3223-9 · Cited by 92
Kang, K. N., Klein, D. R., Kazi, M. I., Guérin, F., Cattoir, V., Brodbelt, J. S., & Boll, J. M. (2019) · Molecular Microbiology · doi:10.1111/mmi.14240 · Cited by 92
Evaluation of colistin stability in agar and comparison of four methods for MIC testing of colistin
Turlej-Rogacka, A., Xavier, B. B., Janssens, L., Lammens, C., Zarkotou, O., Pournaras, S., Goossens, H., & Malhotra‐Kumar, S. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3140-3 · Cited by 88
Lacour, S., Béchet, E., Cozzone, A. J., Mijakovic̀, I., & Grangeasse, C. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003053 · Cited by 86
Dosing of colistin—back to basic PK/PD
Bergen, P. J., Li, J., & Nation, R. L. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.07.004 · Cited by 86
Shen, Y., Xu, C., Sun, Q., Schwarz, Š., Ou, Y., Yang, L., Huang, Z., Eichhorn, I., Walsh, T. R., Wang, Y., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00404-18 · Cited by 82
Börjesson, S., Greko, C., Myrenås, M., Landén, A., Nilsson, O., & Pedersen, K. (2019) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2019.08.007 · Cited by 81
Domalaon, R., Silva, P. M. D., Kumar, A., Zhanel, G. G., & Schweizer, F. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02574-18 · Cited by 80
Olaitan, A. O., Dia, N. M., Gautret, P., Benkouiten, S., Belhouchat, K., Drali, T., Parola, P., Brouqui, P., Memish, Z. A., Raoult, D., et al. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.01.010 · Cited by 78
Chambers, J. R., & Sauer, K. (2013) · Journal of Bacteriology · doi:10.1128/jb.00834-13 · Cited by 78
Luo, J., Yao, X., Lv, L., Doi, Y., Huang, X., Huang, S., & Liu, J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01139-17 · Cited by 76
Colistin Resistance in Enterobacterales Strains – A Current View
STEFANIUK, E. M., & Tyski, S. S. (2019) · Polish Journal of Microbiology · doi:10.33073/pjm-2019-055 · Cited by 71
Lipid A Phosphoethanolamine Transferase: Regulation, Structure and Immune Response
Samantha, A., & Vrielink, A. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.04.022 · Cited by 71
López‐Camacho, E., Gómez-Gil, R., Tobes, R., Manrique, M., Lorenzo, M., Galván, B., Salvarelli, E., Moatassim, Y., Salanueva, Í. J., Pareja, E., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt419 · Cited by 70
Colistin: How should It Be Dosed for the Critically Ill?
Landersdorfer, C. B., & Nation, R. L. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0034-1398390 · Cited by 69
Signal‐specific temporal response by the S almonella PhoP / PhoQ regulatory system
Park, S. J., & Groisman, E. A. (2013) · Molecular Microbiology · doi:10.1111/mmi.12449 · Cited by 69
Molecular mechanisms of polymyxin resistance and detection of mcr genes
Mlynárčik, P., & Kolář, M. (2018) · Biomedical Papers · doi:10.5507/bp.2018.070 · Cited by 69
Morey, P., Viadas, C., Euba, B., Hood, D. W., Barberán, M., Gil, C., Grilló, M. J., Bengoechea, J. A., & Garmendia, J. (2013) · Infection and Immunity · doi:10.1128/iai.00492-13 · Cited by 68
Liu, B., Song, F., Zou, M., Hao, Z., & Shan, H. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01444-16 · Cited by 68
Trauffler, M., Griesbacher, A., Fuchs, K., & Köfer, J. (2014) · Veterinary Record · doi:10.1136/vr.102520 · Cited by 67
Bulman, Z. P., Chen, L., Walsh, T. J., Satlin, M. J., Qian, Y., Bulitta, J. B., Peloquin, C. A., Holden, P. N., Nation, R. L., Li, J., et al. (2017) · mBio · doi:10.1128/mbio.00540-17 · Cited by 66
Formosa‐Dague, C., Herold, M., Vidaillac, C., Duval, R. E., & Dague, É. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv118 · Cited by 65
Zhou, Y., Wang, J., Guo, Y. P., Liu, X., Liu, S., Niu, X., Wang, Y., & Deng, X. (2019) · Journal of Infection · doi:10.1016/j.jinf.2019.03.004 · Cited by 62
Machado, D., Antunes, J., Simões, A., Perdigão, J., Couto, I., McCusker, M. P., Martins, M., Portugal, I., Pacheco, T., Batista, J., et al. (2018) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000741 · Cited by 61
Hu, Y., Liu, Y., & Coates, A. R. M. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01630-18 · Cited by 61
Serratia marcescens arn , a PhoP-Regulated Locus Necessary for Polymyxin B Resistance
Lin, Q. Y., Tsai, Y.-L., Liu, M.-C. J., Lin, W.-C., Hsueh, P., & Liaw, S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00013-14 · Cited by 60
García-Graells, C., Keersmaecker, S. C. J. D., Vanneste, K., Pochet, B., Vermeersch, K., Roosens, N. H. C., Dierick, K., & Botteldoorn, N. (2017) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2017.2329 · Cited by 60
Pterostilbene, a Potential MCR-1 Inhibitor That Enhances the Efficacy of Polymyxin B
Zhou, Y., Liu, S., Wang, T., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02146-17 · Cited by 59
Daly, S. M., Sturge, C. R., Felder-Scott, C. F., Geller, B. L., & Greenberg, D. E. (2017) · mBio · doi:10.1128/mbio.01315-17 · Cited by 56
Janssen, A. B., Doorduijn, D. J., Mills, G., Rogers, M. R. C., Bonten, M. J. M., Rooijakkers, S. H. M., Willems, R. J. L., Bengoechea, J. A., & van Schaik, W. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01958-20 · Cited by 56
Schirmeier, E., Zimmermann, P., Hofmann, V., et al. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.08.027 · Cited by 55
Kluyvera ascorbata Strain from Hospital Sewage Carrying the mcr-1 Colistin Resistance Gene
Zhao, F., & Zong, Z. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01165-16 · Cited by 53
Wei, P., Song, G., Shi, M., Zhou, Y., Liu, Y., Lei, J., Chen, P., & Yin, L. (2017) · The FASEB Journal · doi:10.1096/fj.201700705r · Cited by 53
Momin, M. H. F. A., Bean, D. C., Hendriksen, R. S., Haenni, M., Phee, L. M., & Wareham, D. W. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000602 · Cited by 52
Spread of mcr-1–Driven Colistin Resistance on Hospital Surfaces, Italy
Caselli, E., D’Accolti, M., Soffritti, I., Piffanelli, M., & Mazzacane, S. (2018) · Emerging infectious diseases · doi:10.3201/eid2409.171386 · Cited by 52
Coidentification of mcr-4.3 and bla NDM-1 in a Clinical Enterobacter cloacae Isolate from China
Chavda, B., Lv, J., Hou, M., Chavda, K. D., Kreiswirth, B. N., Feng, Y., Chen, L., & Yu, F. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00649-18 · Cited by 52
Bardet, L., Page, S. L., Leangapichart, T., & Rolain, J. (2017) · BMC Microbiology · doi:10.1186/s12866-017-1128-x · Cited by 51
Cannatelli, A., Principato, S., Colavecchio, O. L., Pallecchi, L., & Rossolini, G. M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01808 · Cited by 51
Zhou, Y., Tao, M.-T., Feng, Y., Yang, R., Liao, X., Liu, Y., & Sun, J. G. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx038 · Cited by 48
Tendon, V. D., Poirel, L., Connolly, L. E., Krause, K. M., & Nordmann, P. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx239 · Cited by 48
Gogry, F. A., Siddiqui, M. T., & Haq, Q. M. R. (2019) · Environmental Science and Pollution Research · doi:10.1007/s11356-019-06561-5 · Cited by 44
Self-citationEmergence of a colistin-resistant Escherichia coli clinical isolate harboring mcr-1 in Japan
Tada, T., Uechi, K., Nakasone, I., Shimada, K., Nakamatsu, M., Kirikae, T., & Fujita, J. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.07.023 · Cited by 43
Lacour, S., Doublet, P., Obadia, B., Cozzone, A. J., & Grangeasse, C. (2006) · Research in Microbiology · doi:10.1016/j.resmic.2006.01.003 · Cited by 38
Zhou, Y., Liu, P., Zhang, C.-J., Liao, X., Sun, J. G., & Liu, Y. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02957 · Cited by 36
Sultan, I., Ali, A., Gogry, F. A., Rather, I. A., Sabir, J. S. M., & Haq, Q. M. R. (2020) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2020.06.002 · Cited by 36
Self-citationRubin, C., Myers, T. R., Stokes, W., Dunham, B., Harris, S., Lautner, B., & Annelli, J. F. (2013) · Emerging infectious diseases · doi:10.3201/eid1912.121659 · Cited by 34
Tryptamine derivatives disarm colistin resistance in polymyxin-resistant gram-negative bacteria
Barker, W. T., Chandler, C. E., Melander, R. J., Ernst, R. K., & Melander, C. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.03.019 · Cited by 31
Lan, X., Hai-tao, Y., Lin, F., Hou, S. X., Li, C., Wang, G., Sun, W., Xiao, J., & Li, S. (2019) · Molecules · doi:10.3390/molecules24152719 · Cited by 27
Saleh, N. M., Hesham, M. S., Amin, M. A., & Samir, R. (2020) · Antibiotics · doi:10.3390/antibiotics9040164 · Cited by 23
Siddiqui, M. T., Mondal, A. H., Sultan, I., Ali, A., & Haq, Q. M. R. (2018) · International Journal of Environmental Science and Technology · doi:10.1007/s13762-018-1939-9 · Cited by 22
Self-citationCheong, H. S., Kim, S. Y., Seo, J., Wi, Y. M., Peck, K. R., & Ko, K. S. (2020) · Current Microbiology · doi:10.1007/s00284-020-02074-4 · Cited by 14
Anandan, A., Piek, S., Kahler, C. M., & Vrielink, A. (2012) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309112042236 · Cited by 6
Cited by
Wang, Y., Ma, X., Zhao, L., He, Y., Yu, W., Fu, S., Ni, W., & Gao, Z. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.868991 · Cited by 27
Metadata
- Authors
- Gogry, F. A., Siddiqui, M. T., Sultan, I., & Haq, Q. M. R.
- Venue
- Frontiers in Medicine
- Publisher
- Frontiers Media SA
- Published
- 2021-08-12
- Volume
- 8
- Pages
- 677720-677720
- ISSN
- 2296-858X (ISSN-L)
- OpenAlex
- W3196187656
- Cited by
- 265
- References
- 181
- FWCI
- 11.66
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.